Isoforms of endothelin-converting enzyme: why and where?

Author： Turner A.J.   Barnes K.   Schweizer A.   Valdenaire O.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.19, Iss.12, 1998-12, pp. : 483-486

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression of human endothelin-converting enzyme isoforms: role of angiotensin II

By Schubert A.   Morawietz H.   Goettsch W.  

Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 6, 2008-06 ,pp. : 299-309

NRC Research Press

Access to resources Recommend Favorite

The membranes of cultured rat brain astrocytes contain endothelin-converting enzyme activity

By Deschepper C.F.   Houweling A.D.   Picard S.  

European Journal of Pharmacology, Vol. 275, Iss. 1, 1995-02 ,pp. : 61-66

Elsevier

Access to resources Recommend Favorite

Endothelin-converting enzyme inhibitors and their potential for cardiovascular and renal therapeutics

By Doggrell Sheila A  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 5, 2004-05 ,pp. : 655-665

Informa Healthcare

Access to resources Recommend Favorite

Phosphono substituted tetrazole derivatives as endothelin-converting enzyme inhibitors

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 3, 1997-03 ,pp. : 277-280

Informa Healthcare

Access to resources Recommend Favorite

Evidence for atypical endothelin receptors and for presence of endothelin-converting enzyme activity in the mouse isolated vas deferens

By Maas J.   D'Orleans-Juste P.   Yano M.   Rae G.A.  

European Journal of Pharmacology, Vol. 276, Iss. 1, 1995-03 ,pp. : 113-121

Elsevier

Access to resources Recommend Favorite